UPDATE 1-Vanda's eczema drug fails mid-stage study, shares fall By: Reuters: Company News March 04, 2015 at 17:43 PM EST March 4 (Reuters) - Vanda Pharmaceuticals Inc said its experimental atopic dermatitis drug failed a mid-stage study to treat chronic itching. Read More >> Related Stocks: Vanda Pharmaceuticals